View of Adjuvant fluorouracil, epirubicin and cyclophosphamide in early breast cancer: Is it cost-effective?

Return to Article Details Adjuvant fluorouracil, epirubicin and cyclophosphamide in early breast cancer: Is it cost-effective? Download Download PDF